ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

NURO NeuroMetrix Inc

4.5114
0.0714 (1.61%)
최종 업데이트: 03:09:26
15분 지연
기업명 주식 심볼 시장 주식 타입
NeuroMetrix Inc NURO 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.0714 1.61% 4.5114 03:09:26
개장가 저가 고가 종가 전일 종가
4.50 4.44 4.65 4.44
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
19/04/202421:00GLOBENeuroMetrix Announces Steps Taken to Enhance Shareholder..
14/03/202422:00GLOBENeuroMetrix Announces Publication of Study Demonstrating..
13/03/202422:00GLOBENeuroMetrix announces that over 2000 patients with..
07/03/202407:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202407:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202407:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202407:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202406:12EDGAR2Form SC 13D/A - General statement of acquisition of..
02/03/202407:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/02/202406:45EDGAR2Form 8-K/A - Current report: [Amend]
28/02/202406:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
27/02/202407:41EDGAR2Form SC 13D - General statement of acquisition of beneficial..
22/02/202421:15EDGAR2Form 8-K - Current report
22/02/202421:00GLOBENeuroMetrix Reports Q4 and Full Year 2023 Business..
21/02/202404:49EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
15/02/202423:00GLOBENeuroMetrix, Inc. Announces Date for Fourth Quarter and Full..
13/02/202423:00GLOBENeuroMetrix Announces Review of Strategic Options to Promote..
12/12/202323:00GLOBENeuroMetrix Reports Encouraging Results from Pilot Clinical..
05/12/202323:00GLOBENeuroMetrix Announces Peer-Reviewed Publication of Phase 2..
20/11/202323:33EDGAR2Form 8-K - Current report
20/11/202323:00GLOBENeuroMetrix Announces One-for-Eight Reverse Stock Split
27/10/202305:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/10/202320:11EDGAR2Form 8-K - Current report
26/10/202320:00GLOBENeuroMetrix Reports Q3 2023 Business Highlights
24/10/202300:13GLOBENeuroMetrix, Inc. Announces Date for Third Quarter 2023..
21/10/202303:59EDGAR2Form 8-K - Current report
02/10/202322:00GLOBENeuroMetrix and the National Fibromyalgia Association to..
11/09/202320:59EDGAR2Form DEF 14A - Other definitive proxy statements
12/08/202306:11EDGAR2Form 8-K - Current report
05/08/202307:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/08/202307:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/08/202307:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/08/202306:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/07/202305:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/07/202305:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/07/202320:24EDGAR2Form 8-K - Current report
27/07/202320:00GLOBENeuroMetrix Reports Q2 2023 Business Highlights
21/07/202302:00GLOBENeuroMetrix, Inc. Announces Date for Second Quarter 2023..
11/07/202322:00GLOBENeuroMetrix Announces Sales Force Expansion for Quell..
28/06/202322:00GLOBERecent Publications Demonstrate Utility of DPNCheck® for..
07/06/202322:00GLOBEDiabetic Peripheral Neuropathy Screening That Includes..
31/05/202322:00GLOBEQuell® Demonstrates Encouraging Clinical Trial Results in..
03/05/202320:00GLOBENeuroMetrix Reports Q1 2023 Financial Results

최근 히스토리

Delayed Upgrade Clock